Compare Home Depot Inc (HD) vs Nuvalent Inc (NUVL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Home Depot Inc vs Nuvalent Inc — how do they compare? Home Depot Inc trades at $330.78 (market cap $332.08B), while Nuvalent Inc trades at $123.96 (market cap $9.81B). The key difference: Home Depot Inc is far larger — about 33.9× Nuvalent Inc's market cap, and Home Depot Inc pays a 2.8% dividend while Nuvalent Inc pays none. Which is the better fit depends on your goals.
| HD | NUVL | |
|---|---|---|
Market Cap | $332.08B | $9.81B |
Sector | Consumer Cyclical | Technology |
52-Week High | $423.42 | $123.96 |
52-Week Low | $297.51 | $72.16 |
Enterprise Value | $393.64B | $8.52B |
Dividend Yield | 2.8% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Home Depot (HD) trades at $331.84, down 2.07% on the day, as the stock faces technical bearish pressure with mixed earnings performance. The company reported Q1 2026 EPS of $3.43, beating expectations, but missed in Q3 2025. Revenue reached $159.51B in 2025 with strong profitability metrics including 8.41% net margin and 128.38% ROE. Recent institutional activity shows mixed positioning while analyst consensus remains bullish with a $370.59 price target.
HD presents a compelling long-term investment case with strong fundamentals and analyst support, though near-term headwinds include weakening big-ticket demand and margin pressure. The stock's current discount to consensus target offers potential upside, but investors should monitor housing market trends and consumer spending patterns that impact home improvement demand.
Nuvalent (NUVL) trades at $123.96, unchanged on the day, with a bullish technical signal from moving averages but overbought oscillators. The company reported a net loss of $425.38 million for 2025 and negative cash flow from operations. Recent news is dominated by GSK's proposed acquisition of Nuvalent for $124 per share, announced in June 2026, which is under investigation by multiple law firms for fairness to shareholders.
The investment outlook is heavily influenced by the pending acquisition. While analyst consensus shows no sell ratings, the stock price is near the offer price, limiting upside. Key risks include the deal's completion and the company's ongoing losses. The primary opportunity is the acquisition premium, but fundamental challenges persist absent the deal.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Home Depot Inc
Home Depot is the world's largest home improvement specialty retailer, operating more than 2,300 warehouse-format stores offering more than 30,000 products in store and 1 million products online in the United States, Canada, and Mexico. Its stores offer numerous building materials, home improvement products, lawn and garden products, and decor products and provide various services, including home improvement installation services and tool and equipment rentals. The acquisition of distributor Interline Brands in 2015 allowed Home Depot to enter the maintenance, repair, and operations business, which has been expanded through the tie-up with HD Supply (2020). The addition of the Company Store brought textile exposure to Home Depot's lineup.
Read more on HD →About Nuvalent Inc
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →
